Masitinib treatment in patients with progressive MS

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Masitinib treatment in patients with progressive MS

Postby MSUK » Wed Jun 13, 2012 2:48 am

Image

Treatment options for patients suffering from progressive forms of multiple sclerosis (MS) remain inadequate. Mast cells actively participate in the pathogenesis of MS, in part because they release large amounts of various mediators that sustain the inflammatory network.

Masitinib, a selective oral tyrosine kinase inhibitor, effectively inhibits the survival, migration and activity of mast cells. This exploratory study assessed the safety and clinical benefit of masitinib in the treatment of primary progressive MS (PPMS) or relapse-free secondary progressive MS (rfSPMS). ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/3226
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2121
Joined: Wed Oct 14, 2009 3:00 pm

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service